Organon (OGN) Non Operating Interest Expenses (2021 - 2026)

Organon has reported Non Operating Interest Expenses for 6 years, with the latest figure at $108.0 million in Q2 2026.

• On a quarterly basis, Non Operating Interest Expenses fell 17.56% year-over-year to $108.0 million in Q2 2026; TTM through Jun 2026 was $468.0 million, a 8.77% decrease from a year earlier, with the FY2025 full-year figure at $504.0 million, down 3.08% from the prior year.
• Non Operating Interest Expenses was $108.0 million for Q2 2026 at Organon, down from $111.0 million in the prior quarter.
• The five-year high for Non Operating Interest Expenses was $134.0 million in Q3 2023, with the low at $97.0 million in Q1 2022.
• Average Non Operating Interest Expenses over 5 years is $121.8 million, with a median of $127.0 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2026: Non Operating Interest Expenses jumped 58.06% in 2022, then decreased 17.56% in 2026.
• Over 5 years, Non Operating Interest Expenses stood at $119.0 million in 2022, then rose by 8.4% to $129.0 million in 2023, then rose by 2.33% to $132.0 million in 2024, then decreased by 8.33% to $121.0 million in 2025, then decreased by 10.74% to $108.0 million in 2026.
• The last three Non Operating Interest Expenses figures came in at $108.0 million (Q2 2026), $111.0 million (Q1 2026), and $121.0 million (Q4 2025), per Business Quant data.